Literatur
Gnant M, Blijham G, Reiner A, Reiner G, Reynders M, Schutte B, Asche C van, Steger G, Jakesz R: DNA Ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomized study. Eur J Cancer (in print).
Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338:327–331.
Early Breast Cancer Trialist Collaborative Group: Effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681–1691.
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Maillard JA: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352–358.
Steger G, Jakesz R: Gegenwärtiger Stand der Adjuvanstherapie bei Patienten mit colorektalem Karzinom: Bericht und Kommentar zur Consensus Konferenz, 16.~18. April 1990, Bethesda. Wien klin Wschr 1991;103:117–121.
Hermanek P: Für und Wider der adjuvanten Chemotherapie des Kolonkarzinoms. Acta chir Austriaca 1991;5/6:230–234.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jakesz, R. Zusammenfassung. Acta Chir Austriaca 23, 247–248 (1991). https://doi.org/10.1007/BF02663239
Issue Date:
DOI: https://doi.org/10.1007/BF02663239